Literature DB >> 19816919

Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat.

Naoki Aizawa1, Yasuhiko Igawa, Osamu Nishizawa, Jean-Jacques Wyndaele.   

Abstract

AIMS: It has been suggested that beta(3)-adrenoceptor (beta(3)-AR) agonists affect not only the efferent but also the afferent pathways innervating the bladder. In addition, prostaglandin E(2) (PGE(2)) causes bladder hyperactivity in conscious rats. We investigated the direct effects of a beta(3)-AR agonist (CL316,243; CL) and PGE(2) on single fiber activities of the primary bladder afferent nerves.
METHODS: Female Sprague-Dawley rats were used. Under urethane anesthesia, a single nerve fiber primarily originating from the bladder was identified by electrical stimulation of the left pelvic nerve and by bladder distention, and was divided by conduction velocity (2.5 m/sec) as A delta-fiber or C-fiber. The afferent activity measurements with constant bladder filling were repeated three times and the third measurement served as the base-line observation. Then, CL (10 microg/kg) or its vehicle was administrated intravenously. Thereafter, 10(-4) M of PGE(2) or saline was instilled intravesically and another three cycles recorded.
RESULTS: Forty-three single afferent fibers (A delta-fibers: n = 20, C-fibers: n = 23) were isolated from 34 rats. Intravenous administration of CL, but not vehicle, significantly decreased A delta-fiber, but not C-fiber, activities in response to bladder filling with saline. Intravesical instillation of PGE(2) significantly increased C-fiber activities, but not A delta-fiber activities. The PGE(2)-induced increase in C-fiber activities was inhibited by pretreatment with CL.
CONCLUSIONS: The present results clearly demonstrate that the beta(3)-AR agonist, CL316,243, can inhibit the mechanosensitive A delta-fibers, but not the C-fibers, of the primary bladder afferents of the rat. In addition, the beta(3)-AR agonist can inhibit PGE(2)-induced C-fiber hyperactivity. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19816919     DOI: 10.1002/nau.20826

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  29 in total

1.  Stimulation of the pelvic nerve increases bladder capacity in the prostaglandin E2 rat model of overactive bladder.

Authors:  Christopher L Langdale; James A Hokanson; Arun Sridhar; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-14

2.  Recovery of urothelial mediator release but prolonged elevations in interleukin-8 and nitric oxide secretion following mitomycin C treatment.

Authors:  Sung Hyun Kang; Russ Chess-Williams; Shailendra Anoopkumar-Dukie; Catherine McDermott
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-03       Impact factor: 3.000

Review 3.  β3 -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions?

Authors:  Yasuhiko Igawa; Naoki Aizawa; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-05-03       Impact factor: 8.739

Review 4.  Urothelial signaling.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

5.  Drugs and future candidates.

Authors:  Karl-Erik Andersson
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

6.  Enhanced urothelial ATP release and contraction following intravesical treatment with the cytotoxic drug, doxorubicin.

Authors:  Sung-Hyun Kang; Catherine McDermott; Stefanie Farr; Russ Chess-Williams
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-17       Impact factor: 3.000

7.  Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.

Authors:  Toshiki Hatanaka; Masashi Ukai; Mai Watanabe; Akiyoshi Someya; Akiyoshi Ohtake; Masanori Suzuki; Koji Ueshima; Shuichi Sato; Seiji Kaku
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

8.  Is pretreatment cystometry important in predicting response to mirabegron in women with overactive bladder symptoms?

Authors:  Maya Basu; Aswini Balachandran; Jonathan Duckett
Journal:  Int Urogynecol J       Date:  2015-08-19       Impact factor: 2.894

9.  Tissue functions mediated by beta(3)-adrenoceptors-findings and challenges.

Authors:  Martin C Michel; Peter Ochodnicky; Roger J Summers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-03       Impact factor: 3.000

Review 10.  β3-receptor agonists for overactive bladder--new frontier or more of the same?

Authors:  Karl-Erik Andersson
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.